Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 30, 2025
Event: Entry into a Material Definitive Agreement regarding a new credit facility.
Key Financial Metrics
This filing reports on a new financing arrangement rather than operational performance metrics. Specific data points include:
- New Credit Facility: $5.0 billion unsecured revolving credit agreement.
- Previous Facility: Replaces a $2.642 billion 5-year agreement and a $2.1 billion 364-day agreement.
- Outstanding Borrowings: $0 as of May 30, 2025.
- Letters of Credit: Approximately $14.7 million issued and undrawn.
- Remaining Capacity: Approximately $4.98 billion.
- Incremental Capacity: Agreement permits up to $1.0 billion in additional commitments.
Note: The filing text does not provide values for revenue, profit, cash flow, margins, or total debt levels outside of this specific credit facility.
Material Changes
The primary material change is the amendment and restatement of the company's existing credit facilities:
- Capacity Increase: Commitments increased from $2.642 billion to $5.0 billion.
- Structure Change: Consolidates the previous 5-year and 364-day agreements into a single new Revolving Credit Agreement.
- Interest Terms: Loans bear interest at Term SOFR, Daily Simple SOFR, or the base rate plus a spread.
- Fees: The Company will pay an annual facility fee regardless of utilization.
Outlook, Risks, and Management Commentary
Covenants and Conditions: The agreement includes customary covenants, specifically a maximum debt to capitalization covenant, and standard events of default. Borrowing is subject to customary representations and warranties.
Related Parties: Humana maintains other relationships, including financial advisory and banking, with some of the parties to the Revolving Credit Agreement (e.g., JPMorgan Chase, Bank of America, Citibank, Goldman Sachs, PNC, U.S. Bank, Wells Fargo).
Documentation: The full text of the Revolving Credit Agreement will be filed as an exhibit to the Company's Quarterly Report on Form 10-Q for the six months ending June 30, 2025.
Investor Verification Checklist
- Verify the specific interest rate spreads and facility fee percentages in the full agreement text (to be filed in the upcoming 10-Q).
- Review the "maximum debt to capitalization" covenant thresholds to understand borrowing constraints.
- Confirm the total consolidated debt load of the company to assess the impact of the new $5.0 billion capacity on leverage ratios.
- Monitor the utilization of the $1.0 billion incremental commitment option.